- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01.09. | Dose-at-home Leqembi for Alzheimer's cleared in US | ||
| 29.08. | Trump appoints HHS deputy O'Neill to lead CDC | ||
| 29.08. | UK adds chickenpox to childhood vaccination schedule | ||
| 28.08. | Outlook blindsided as FDA blocks wet AMD drug once again | ||
| 28.08. | Novo reels in Replicate for new cardiometabolic drugs | ||
| 28.08. | Scoop: Lumos Labs has FDA nod for ADHD DtX Prismira | ||
| 28.08. | Lilly pauses Mounjaro shipments to UK ahead of price hike | ||
| 28.08. | Stada revives talk of an IPO - if conditions improve | ||
| 28.08. | Lilly raises stakes in Novartis battle with Verzenio data | ||
| 28.08. | CDC director refuses to step down after being fired | ||
| 27.08. | FDA ends emergency COVID authorisations, issues narrow approvals | ||
| 27.08. | Survey reveals 'trust gap' in the value of AI to cardiology | ||
| 27.08. | ESC: Study says GLP-1s treat heart failure AND cut emissions | ||
| 27.08. | Nykode changes tack after Roche exits partnership | ||
| 27.08. | Bayer files 'safer, greener' MRI contrast agent in US | ||
| 26.08. | Regeneron preps filings for myasthenia gravis drug | ||
| 26.08. | EVERSANA buys digital drug-price marketplace firm Waltz Health | ||
| 26.08. | Diabetics on Lilly's orforglipron shed 10.5% of their weight | ||
| 26.08. | Gilead poised to bring twice-yearly HIV PrEP to EU | ||
| 26.08. | Roche breaks ground on US manufacturing facility | ||
| 26.08. | Alzheimer's drug Leqembi launched in first EU markets | ||
| 25.08. | Rumour partly confirmed as AbbVie acquires Gilgamesh drug | ||
| 25.08. | Radiopharma CDMO Nucleus names former FDA boss as CEO | ||
| 25.08. | RWE study shows promise for digital treatment of adult ADHD | ||
| 25.08. | Argenx poised to expand Vyvgart market off new phase 3 data |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .